Nonseminomatous germ cell tumor: Clinical Trials

1 trial for Nonseminomatous germ cell tumor, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Active not recruiting 1

Follow Nonseminomatous germ cell tumor: new trials by email Literature Review of Nonseminomatous germ cell tumor trials Research Report on Nonseminomatous germ cell tumor

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Standard-Dose Combination Chemotherapy or High-Dose Combination Chemotherapy and Stem Cell Transplant in Treating Patients With Relapsed or Refractory Germ Cell Tumors
paclitaxel, ifosfamide, cisplatin - Germ Cell Tumor, Teratoma
Phase 3Active not recruitingAlliance for Clinical Trials in Oncology4202015-08-062026-06-16

Narrower conditions

Choriocarcinoma (1)  ·  Endodermal Sinus Tumor (1)  ·  Germinoma (1)  ·  Neoplasms, Germ Cell and Embryonal (1)  ·  Seminoma (1)  ·  Teratoma (1)

Broader conditions

Adenocarcinoma (1)  ·  Carcinoma (1)  ·  Female Urogenital Diseases and Pregnancy Complications (1)  ·  Mesonephroma (1)  ·  Neoplasms (1)  ·  Neoplasms by Histologic Type (1)  ·  Neoplasms, Glandular and Epithelial (1)  ·  Pregnancy Complications (1)  ·  Pregnancy Complications, Neoplastic (1)  ·  Trophoblastic Neoplasms (1)  ·  Urogenital Diseases (1)

Interventions

Carboplatin (1)  ·  Cisplatin (1)  ·  Etoposide (1)  ·  Granulocyte Colony-Stimulating Factor (1)  ·  Ifosfamide (1)  ·  Paclitaxel (1)  ·  etoposide phosphate (1)

Sponsors

Alliance for Clinical Trials in Oncology (1)

Countries

Australia (1)  ·  Belgium (1)  ·  Denmark (1)  ·  France (1)  ·  Germany (1)  ·  Ireland (1)  ·  Italy (1)  ·  Netherlands (1)  ·  Spain (1)  ·  Switzerland (1)  ·  United Kingdom (1)  ·  United States (1)

Top investigators

Darren Feldman, MD (1)

Results publications

PMID 30563754, PMID 39028926

NIH funding

U10CA180821 (1)